I agree that this site is using cookies. You can find further informations here.
X
Reece, Donna
252  results:
Search for persons X
?
1

Tandem Autologous Stem Cell Transplantation Does Not Benefi..:

Venner, Christopher P. ; Duggan, Peter ; Song, Kevin...
Transplantation and Cellular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Daratumumab for patients with myeloma with early or late re..:

Spencer, Andrew ; Moreau, Philippe ; Mateos, Maria-Victoria...
Blood Advances.  8 (2024)  2 - p. 388-398 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Long‐term follow‐up of outcomes including progression‐free ..:

Kaedbey, Rayan ; Reece, Donna ; Venner, Christopher P....
eJHaem.  5 (2024)  3 - p. 474-484 , 2024
Link: https://doi.org/10.1002/..
 
?
4

Belantamab mafodotin, pomalidomide and dexamethasone in ref..:

Trudel, Suzanne ; McCurdy, Arleigh ; Louzada, Martha L....
Nature Medicine.  30 (2024)  2 - p. 543-551 , 2024
Link: https://doi.org/10.1038/..
 
?
5

The Impact of CD34+ Cell Collection Yields for Autologous T..:

Lebel, Eyal ; Lajkosz, Katherine ; Masih-Khan, Esther...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  11 - p. 850-856 , 2023
Link: https://doi.org/10.1016/..
 
?
6

MM-371 Pomalidomide, Daratumumab, and Dexamethasone After L..:

Bahlis, Nizar J. ; Samaras, Christy ; Reece, Donna...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S494-S495 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Redefining attrition in multiple myeloma (MM): a Canadian M..:

McCurdy, Arleigh ; Mian, Hira ; LeBlanc, Richard...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
8

Correction: Redefining attrition in multiple myeloma (MM): ..:

McCurdy, Arleigh ; Mian, Hira ; LeBlanc, Richard...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
9

POSTER: MM-371 Pomalidomide, Daratumumab, and Dexamethasone..:

Bahlis, Nizar J. ; Samaras, Christy ; Reece, Donna...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S225 , 2023
Link: https://doi.org/10.1016/..
 
?
10

P888: MATCHED-ADJUSTED INDIRECT COMPARISON OF TALQUETAMAB V..:

Chari, Ajai ; Diels, Joris ; Van Sanden, Suzy...
HemaSphere.  7 (2023)  S3 - p. e81043cc , 2023
Link: https://doi.org/10.1097/..
 
?
11

Phase 1/2 study of carfilzomib, pomalidomide, and dexametha..:

Derman, Benjamin A. ; Zonder, Jeffrey ; Reece, Donna...
Blood Advances.  7 (2023)  19 - p. 5703-5712 , 2023
Link: https://doi.org/10.1182/..
 
?
12

P-291 Outcomes of third-line therapy in multiple myeloma pa..:

Louzada, Martha ; Reece, Donna ; Venner, Christopher...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S197 , 2023
Link: https://doi.org/10.1016/..
 
?
13

The Canadian Registry for Amyloidosis Research: A national ..:

Massie, Rami ; Delgado, Diego ; Venner, Christopher...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
14

Post Salvage Therapy Autologous Transplant for Relapsed Mye..:

Khan, Sahar ; Reece, Donna ; Atenafu, Eshetu G....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  2 - p. e97-e106 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Clinical evidence for immune-based strategies in early-line..:

Raje, Noopur ; Mateos, María-Victoria ; Iida, Shinsuke.
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
1-15